MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
Christina Charles-SchoemanErnest H S ChoyIain B McInnesEduardo MyslerPeter NashKunihiro YamaokaRalph LippeNasser KhanAnna K ShmagelHannah PalacJessica SubotickiJeffrey R CurtisPublished in: RMD open (2023)
RA (SELECT-NEXT: NCT02675426; SELECT-MONOTHERAPY: NCT02706951; SELECT-BEYOND: NCT02706847; SELECT-COMPARE: NCT02629159; SELECT-EARLY: NCT02706873, SELECT-CHOICE: NCT03086343), PsA (SELECT-PsA 2: NCT03104374; SELECT-PsA 1: NCT03104400), and AS (SELECT-AXIS 1: NCT03178487).